U.S. Policy Shifts: New “Infant Formula Made in America Act”, “Protect Infant Formula from Contamination Act” - What Do They Imply?
Fast Company Honors Bobbie as a 2026 Innovator: Launching the first USDA Organic Whole Milk infant formula made in the U.S. – Meet them In June
Nūmi® has achieved its first in‑house 50‑liter bioreactor run, marking a key milestone in proving its human‑milk bioactive production process can scale. - Meet them in June

Lactoferrin & Next-Generation Recombinant Proteins Shaping the Future of Infant Formula

By | 16 February 2026

Exploring strategic pathways for recombinant LF that balance commercial opportunities in adult nutrition with extended regulatory timelines in infant nutrition
Examining how LF bridges functional bioactive gaps between breast milk and formula to support improved infant health outcomes, including discussion of a preclinical infant mouse study evaluating the effects of oral LF on the gut microbiome and intestinal barrier
Translating lessons from previous novel ingredient launches in infant formula into actionable approaches for regulatory approval and geographic expansion